IL89156A - Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics - Google Patents
Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeuticsInfo
- Publication number
- IL89156A IL89156A IL89156A IL8915689A IL89156A IL 89156 A IL89156 A IL 89156A IL 89156 A IL89156 A IL 89156A IL 8915689 A IL8915689 A IL 8915689A IL 89156 A IL89156 A IL 89156A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- group
- tetrahydroisoquinoline
- piperidinyl
- therapeutics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809447A FR2634204B2 (fr) | 1987-08-07 | 1988-07-12 | Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
IL89156A0 IL89156A0 (en) | 1989-09-10 |
IL89156A true IL89156A (en) | 1993-05-13 |
Family
ID=9368349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL89156A IL89156A (en) | 1988-07-12 | 1989-02-02 | Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics |
Country Status (15)
Country | Link |
---|---|
US (1) | US4925850A (no) |
EP (1) | EP0351255B1 (no) |
JP (1) | JPH0225481A (no) |
KR (1) | KR900001676A (no) |
AT (1) | ATE95816T1 (no) |
AU (1) | AU606778B2 (no) |
DE (1) | DE68909855D1 (no) |
DK (1) | DK50089A (no) |
FI (1) | FI890520A (no) |
HU (1) | HU201543B (no) |
IL (1) | IL89156A (no) |
NO (1) | NO171786C (no) |
NZ (1) | NZ227853A (no) |
PT (1) | PT89643B (no) |
ZA (1) | ZA89905B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3717561A1 (de) * | 1987-05-25 | 1988-12-08 | Thomae Gmbh Dr K | Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
EP0306375A1 (fr) * | 1987-08-07 | 1989-03-08 | Synthelabo | Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique |
FR2661178B1 (fr) * | 1990-04-24 | 1993-03-12 | Synthelabo | Derives de [(tetrahydro-1,2,3,4 isoquinoleinyl-2)methyl]-4 piperidinecarboxylates-1 d'alkyle, leur preparation et leur application en therapeutique. |
US5132311A (en) * | 1990-06-27 | 1992-07-21 | G. D. Searle & Co. | Cyanoquanidine type III antiarrhythmic agents and use |
FR2747386B1 (fr) * | 1996-04-12 | 1998-05-15 | Synthelabo | Derives de 3-[(1,2,3,4-tetrahydroisoquinolein-2-yl)methyl] -8-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique |
AU4204697A (en) * | 1996-08-14 | 1998-03-06 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives and their pharmaceutical use |
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
MA26696A1 (fr) | 1998-10-08 | 2004-12-20 | Smithkline Beecham Plc | Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |
DE10060176B4 (de) | 2000-12-04 | 2008-06-19 | Precitec Kg | Laserbearbeitungskopf |
KR101042208B1 (ko) * | 2008-09-26 | 2011-06-20 | 현대종합금속 주식회사 | 셀프 쉴디드(self-shielded) 아크 용접 플럭스 충전 와이어 |
AU2010264422B2 (en) | 2009-06-26 | 2014-12-18 | Sanofi | Novel fumarate salts of a histamine H3 receptor antagonist |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1580180A (no) * | 1967-03-14 | 1969-09-05 | ||
FR7607M (no) * | 1968-04-25 | 1970-01-19 | ||
GB1250719A (no) * | 1969-03-19 | 1971-10-20 | ||
US3836536A (en) * | 1972-06-08 | 1974-09-17 | Warner Lambert Co | 1,2,3,4-tetrahydro-3-aminomethyliso-quinolines |
FR2426046A1 (fr) * | 1978-05-18 | 1979-12-14 | Synthelabo | Derive de tetrahydro-isoquinoleine, sa preparation et son application en therapeutique |
US4220778A (en) * | 1978-10-30 | 1980-09-02 | G. D. Searle & Co. | 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof |
US4766131A (en) * | 1980-10-17 | 1988-08-23 | Pennwalt Corporation | 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics |
DE3717561A1 (de) * | 1987-05-25 | 1988-12-08 | Thomae Gmbh Dr K | Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
EP0306375A1 (fr) * | 1987-08-07 | 1989-03-08 | Synthelabo | Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique |
-
1989
- 1989-02-02 IL IL89156A patent/IL89156A/xx not_active IP Right Cessation
- 1989-02-03 PT PT89643A patent/PT89643B/pt active IP Right Grant
- 1989-02-03 DE DE89400306T patent/DE68909855D1/de not_active Expired - Lifetime
- 1989-02-03 NO NO890440A patent/NO171786C/no unknown
- 1989-02-03 AU AU29617/89A patent/AU606778B2/en not_active Ceased
- 1989-02-03 DK DK050089A patent/DK50089A/da not_active Application Discontinuation
- 1989-02-03 AT AT89400306T patent/ATE95816T1/de not_active IP Right Cessation
- 1989-02-03 NZ NZ227853A patent/NZ227853A/en unknown
- 1989-02-03 FI FI890520A patent/FI890520A/fi not_active Application Discontinuation
- 1989-02-03 EP EP89400306A patent/EP0351255B1/fr not_active Expired - Lifetime
- 1989-02-04 KR KR1019890001304A patent/KR900001676A/ko not_active Application Discontinuation
- 1989-02-06 JP JP1027326A patent/JPH0225481A/ja active Pending
- 1989-02-06 ZA ZA89905A patent/ZA89905B/xx unknown
- 1989-02-06 US US07/306,497 patent/US4925850A/en not_active Expired - Fee Related
- 1989-02-06 HU HU89565A patent/HU201543B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI890520A (fi) | 1990-01-13 |
ZA89905B (en) | 1989-10-25 |
NO171786B (no) | 1993-01-25 |
FI890520A0 (fi) | 1989-02-03 |
EP0351255A3 (en) | 1990-05-02 |
IL89156A0 (en) | 1989-09-10 |
US4925850A (en) | 1990-05-15 |
NO171786C (no) | 1993-05-05 |
NZ227853A (en) | 1990-06-26 |
NO890440D0 (no) | 1989-02-03 |
HUT50327A (en) | 1990-01-29 |
HU201543B (en) | 1990-11-28 |
PT89643B (pt) | 1994-02-28 |
DK50089D0 (da) | 1989-02-03 |
NO890440L (no) | 1990-01-15 |
DK50089A (da) | 1990-01-13 |
KR900001676A (ko) | 1990-02-27 |
ATE95816T1 (de) | 1993-10-15 |
EP0351255A2 (fr) | 1990-01-17 |
EP0351255B1 (fr) | 1993-10-13 |
AU2961789A (en) | 1990-01-18 |
DE68909855D1 (de) | 1993-11-18 |
PT89643A (pt) | 1989-10-04 |
AU606778B2 (en) | 1991-02-14 |
JPH0225481A (ja) | 1990-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT44044A (en) | Process for preparing place-specific alkylating agents | |
DE3888756D1 (de) | Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung. | |
IL89156A (en) | Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics | |
SE8603099L (sv) | Distamycinderivat och forfarande for deras framstellning | |
SE8403801L (sv) | Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem | |
DE69125811D1 (de) | Verfahren zur Herstellung substituierter Benzofuranderivate | |
HUT42440A (en) | Process for preparing novel indole-carboxamide derivatives and pharmaceutical compositions comprising such compounds | |
CS183791A3 (en) | Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and their therapeutical application | |
ES8707226A1 (es) | Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol | |
KR910007928A (ko) | 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물 | |
DK316589A (da) | Substituerede azacyclohexylderivater af rifamyciner | |
SE8800863D0 (sv) | 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith | |
ES2131015A1 (es) | Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas. | |
SE8005493L (sv) | 4-(haftalenyloxi)piperidin-derivat | |
SE8605458L (sv) | 4-hydroxikumaring-derivat | |
SE8405338D0 (sv) | (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
FI933468A (fi) | Tetrahydronaftalenderivat, framstaellning av dessa och terapeutisk anvaendning av dessa | |
IL97611A (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9K | Patent not in force due to non-payment of renewal fees |